ConductScience.org, home

Paper34909643

Tuberculosis and pharmacological interactions: A narrative review.

Riccardi N and 7 others. Curr Res Pharmacol Drug Discov, 2021. Cited by 30 papers, by iCite.

Cite this record

ConductScience Library. Tuberculosis and pharmacological interactions: A narrative review. Papers, record 34909643. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34909643

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Tuberculosis and pharmacological interactions: A narrative review.
PubMed
Journal
Curr Res Pharmacol Drug Discov
PubMed
Year
2021
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
30
iCite
Relative citation ratio, by iCite
1.85
iCite
Revised in PubMed
2024-08-19
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Riccardi NNiccolò
2Canetti DDiana
3Rodari PPaola
4Besozzi GGiorgio
5Saderi LLaura
6Dettori MMarco
7Codecasa LRLuigi R
8Sotgiu GGiovanni

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References94

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
11436277Effect of pyrazinamide on ciclosporin levels.Nephron1992https://conductscience.org/library/papers/1436277PubMed
232741532From the past, a long way to future challenges for a greater control of tuberculosis.Tuberculosis (Edinb)2020https://conductscience.org/library/papers/32741532PubMed
34074601Influence of rifampicin and isoniazid on the kinetics of phenytoin.Br J Clin Pharmacol1985https://conductscience.org/library/papers/4074601PubMed
49433391Rifampin reduces plasma concentrations and effects of zolpidem.Clin Pharmacol Ther1997https://conductscience.org/library/papers/9433391PubMed
521521707Linezolid pharmacokinetics and pharmacodynamics in clinical treatment.J Antimicrob Chemother2011https://conductscience.org/library/papers/21521707PubMed
618486041Cycloserine.Tuberculosis (Edinb)2008https://conductscience.org/library/papers/18486041PubMed
731729908Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline.Am J Respir Crit Care Med2019https://conductscience.org/library/papers/31729908PubMed
826747099Drug-drug interactions between bedaquiline and the antiretrovirals lopinavir/ritonavir and nevirapine in HIV-infected patients with drug-resistant TB.J Antimicrob Chemother2016https://conductscience.org/library/papers/26747099PubMed
928240570Delamanid in the treatment of multidrug-resistant tuberculosis.Int J Tuberc Lung Dis2016https://conductscience.org/library/papers/28240570PubMed
1012426514Rifampin markedly decreases plasma concentrations of praziquantel in healthy volunteers.Clin Pharmacol Ther2002https://conductscience.org/library/papers/12426514PubMed
117431585Rifampin and digoxin: possible drug interaction in a dialysis patient.JAMA1980https://conductscience.org/library/papers/7431585PubMed
1211253855Risk assessment for antimicrobial agent-induced QTc interval prolongation and torsades de pointes.Pharmacotherapy2001https://conductscience.org/library/papers/11253855PubMed
1314748817Effect of rifampicin on pravastatin pharmacokinetics in healthy subjects.Br J Clin Pharmacol2004https://conductscience.org/library/papers/14748817PubMed
1432060065Bedaquiline resistance in drug-resistant tuberculosis HIV co-infected patients.Eur Respir J2020https://conductscience.org/library/papers/32060065PubMed
1510954343Effects of rifampicin and cimetidine on pharmacokinetics and pharmacodynamics of lamotrigine in healthy subjects.Eur J Clin Pharmacol2000https://conductscience.org/library/papers/10954343PubMed
161345893Case report: nifedipine-rifampicin interaction attenuates the effect on blood pressure in a patient with essential hypertension.Am J Med Sci1992https://conductscience.org/library/papers/1345893PubMed
1727270559Rifamycins, Alone and in Combination.Cold Spring Harb Perspect Med2016https://conductscience.org/library/papers/27270559PubMed
189272811Loss of analgesic effect of morphine due to coadministration of rifampin.Pain1997https://conductscience.org/library/papers/9272811PubMed
1931144345The interaction between rifampicin and lamotrigine: A case report.Br J Clin Pharmacol2019https://conductscience.org/library/papers/31144345PubMed
2031704175Pharmacological and Molecular Mechanisms Behind the Sterilizing Activity of Pyrazinamide.Trends Pharmacol Sci2019https://conductscience.org/library/papers/31704175PubMed

See all 94 referencesDownload CSV of references

Cited by22

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 30 citations.

PMIDTitleJournalYearIn PapersSource
42742880Exploring the impact of nutrition and autophagy on infectious diseases to inform the development of homeostatic-nanomedicines for HIV-TB coinfections.Discov Nano2026https://conductscience.org/library/papers/42742880PubMed
42662901Enrichment of CD4-CD8- cytotoxic Vδ1/3 T cells in pulmonary tuberculosis disease.iScience2026https://conductscience.org/library/papers/42662901PubMed
40869505Tuberculosis in Pregnant Women After COVID-19: Features of Prevention, Diagnosis, and Treatment (Narrative Review).J Clin Med2025https://conductscience.org/library/papers/40869505PubMed
40727383Pharmacokinetic Profile of Isoniazid and Acetylator Status in Patients with Systemic Lupus Erythematosus: Implications for Tuberculosis Prevention Therapy in Indonesia.Infect Drug Resist2025https://conductscience.org/library/papers/40727383PubMed
40654283Gut microbiota and tuberculosis infection: interaction and therapeutic potential.Gut Microbes2025https://conductscience.org/library/papers/40654283PubMed
40176807Recent advances in immunopathogenesis and clinical practice: mastering the challenge-managing of non-tuberculous mycobacteria.Front Immunol2025https://conductscience.org/library/papers/40176807PubMed
40104255The importance of getting the dose right in the treatment of tuberculosis.Breathe (Sheff)2025https://conductscience.org/library/papers/40104255PubMed
40060746The risk of developing depression in tuberculosis survivors: a nationwide cohort study in South Korea.Front Psychiatry2025https://conductscience.org/library/papers/40060746PubMed
39697659Combination of gallium citrate and levofloxacin induces a distinct metabolome profile and enhances growth inhibition of multidrug-resistant Mycobacterium tuberculosis compared to linezolid.Front Microbiol2024https://conductscience.org/library/papers/39697659PubMed
39234233ISCCM Position Statement on the Approach to and Management of Critically Ill Patients with Tuberculosis.Indian J Crit Care Med2024https://conductscience.org/library/papers/39234233PubMed
39204140Drug-Drug Interactions between COVID-19 and Tuberculosis Medications: A Comprehensive Review of CYP450 and Transporter-Mediated Effects.Pharmaceuticals (Basel)2024https://conductscience.org/library/papers/39204140PubMed
38783925Breaking barriers: The potential of nanosystems in antituberculosis therapy.Bioact Mater2024https://conductscience.org/library/papers/38783925PubMed
38766427Tuberculosis-diabetes comorbidities: Mechanistic insights for clinical considerations and treatment challenges.World J Diabetes2024https://conductscience.org/library/papers/38766427PubMed
38136767How We Treat Drug-Susceptible Pulmonary Tuberculosis: A Practical Guide for Clinicians.Antibiotics (Basel)2023https://conductscience.org/library/papers/38136767PubMed
37987471Potential Drug-Drug Interactions and Related Factors among Geriatric Outpatients of a Tertiary Care Hospital.Geriatrics (Basel)2023https://conductscience.org/library/papers/37987471PubMed
37547037Tuberculosis in older adults: challenges and best practices in the Western Pacific Region.Lancet Reg Health West Pac2023https://conductscience.org/library/papers/37547037PubMed
37508267Management of Polypharmacy and Potential Drug-Drug Interactions in Patients with Mycobacterial Infection: A 1-Year Experience of a Multidisciplinary Outpatient Clinic.Antibiotics (Basel)2023https://conductscience.org/library/papers/37508267PubMed
36538813Advances in the design of combination therapies for the treatment of tuberculosis.Expert Opin Drug Discov2023https://conductscience.org/library/papers/36538813PubMed
36105740Pretomanid for tuberculosis treatment: an update for clinical purposes.Curr Res Pharmacol Drug Discov2022https://conductscience.org/library/papers/36105740PubMed
35650702Clinical standards for the dosing and management of TB drugs.Int J Tuberc Lung Dis2022https://conductscience.org/library/papers/35650702PubMed

See all 22 cited byDownload CSV of cited by

Genes13

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/34909643

GET https://conductscience.org/api/papers/v1/34909643/references?page=2